Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
NXTM [NASD]
Nxstage Medical, Inc.
Index- P/E- EPS (ttm)-0.37 Insider Own1.70% Shs Outstand61.83M Perf Week8.67%
Market Cap914.47M Forward P/E- EPS next Y-0.34 Insider Trans17.96% Shs Float57.57M Perf Month14.56%
Income-22.60M PEG- EPS next Q-0.13 Inst Own95.30% Short Float6.38% Perf Quarter10.37%
Sales282.60M P/S3.24 EPS this Y-19.20% Inst Trans-0.01% Short Ratio13.12 Perf Half Y29.17%
Book/sh3.09 P/B4.79 EPS next Y24.40% ROA-7.30% Target Price17.50 Perf Year7.96%
Cash/sh1.00 P/C14.73 EPS next 5Y20.00% ROE-11.70% 52W Range8.77 - 15.65 Perf YTD47.90%
Dividend- P/FCF- EPS past 5Y24.10% ROI-9.00% 52W High-5.50% Beta0.61
Dividend %- Quick Ratio2.10 Sales past 5Y15.40% Gross Margin38.90% 52W Low68.64% ATR0.42
Employees3200 Current Ratio3.10 Sales Q/Q13.10% Oper. Margin-7.20% RSI (14)74.02 Volatility2.99% 2.99%
OptionableYes Debt/Eq0.10 EPS Q/Q-100.00% Profit Margin-8.00% Rel Volume1.29 Prev Close14.62
ShortableYes LT Debt/Eq0.09 EarningsNov 06 BMO Payout- Avg Volume279.67K Price14.79
Recom1.90 SMA2010.29% SMA5010.58% SMA20011.38% Volume361,472 Change1.16%
03-May-13Reiterated Feltl & Co. Hold $11.50 → $12
01-Mar-13Reiterated Feltl & Co. Hold $13 → $11.50
04-Dec-12Downgrade Northland Securities Outperform → Market Perform
07-Sep-12Initiated Northland Securities Outperform $18
18-Feb-11Reiterated Rodman & Renshaw Mkt Underperform $15 → $18
03-Dec-10Initiated Jefferies Buy $27
14-Oct-10Downgrade Rodman & Renshaw Mkt Perform → Mkt Underperform $15
15-Sep-10Initiated Feltl & Co. Buy $19
26-Jul-10Downgrade Rodman & Renshaw Mkt Outperform → Mkt Perform
06-May-10Reiterated Rodman & Renshaw Mkt Outperform $11 → $14
08-Jan-10Initiated Rodman & Renshaw Mkt Outperform $11
05-Jun-09Upgrade William Blair Mkt Perform → Outperform
06-Aug-08Reiterated SMH Capital Buy $8 → $7
06-Aug-08Reiterated Canaccord Adams Hold $7 → $4.75
29-Jul-08Initiated SMH Capital Buy $8
14-May-08Reiterated JMP Securities Mkt Outperform $13 → $10
13-May-08Downgrade William Blair Outperform → Mkt Perform
13-May-08Downgrade Canaccord Adams Buy → Hold $12 → $7
13-Feb-08Reiterated SMH Capital Buy $18 → $13
13-Feb-08Reiterated JMP Securities Mkt Outperform $17 → $13
24-Oct-14 08:00AM  NxStage Director of Public Policy Honored for Dedication to Patient Advocacy PR Newswire
08-Oct-14 01:04PM  NXSTAGE MEDICAL, INC. Financials EDGAR Online Financials
09:57AM  NxStage Kidney Care Hosts Grand Opening Event at Florida Dialysis Center PR Newswire
07-Oct-14 08:00AM  NxStage® to Report Third Quarter 2014 Financial Results PR Newswire
01-Oct-14 05:01PM  NXSTAGE MEDICAL, INC. Files SEC form 10-Q/A, Quarterly Report EDGAR Online
16-Sep-14 08:00AM  NxStage Announces FDA Clearance of Single Needle Technology PR Newswire
10-Sep-14 08:00AM  NxStage Patients Participate in 257-Mile Tour DaVita Bike Ride PR Newswire
20-Aug-14 10:00AM  NxStage Kidney Care Opens New Orlando Florida Dialysis Center PR Newswire
12-Aug-14 08:00AM  Allan J. Collins, M.D., to join NxStage as Senior Medical Advisor PR Newswire
07-Aug-14 08:07AM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh EDGAR Online +5.98%
07:54AM  NXSTAGE MEDICAL, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
07:38AM  NxStage Reports Record Second Quarter 2014 Financial Results And Increases Full-Year Revenue Guidance PR Newswire
07:07AM  Q2 2014 NxStage Medical, Inc. Earnings Release - Before Market Open CCBN
01-Aug-14 08:00AM  NxStage to Present at the 34th Annual Canaccord Genuity Growth Conference PR Newswire
17-Jul-14 08:01AM  NxStage® to Report Second Quarter 2014 Financial Results PR Newswire
16-Jul-14 10:09AM  NxStage Drives to Educate Kidney Patients PR Newswire
08-Jul-14 05:35PM  Mariel Therapeutics Acquires Stryker Assets Zacks
08:00AM  NxStage Kidney Care Hosts Grand Opening Celebration Of New State-Of-The-Art Dialysis Center In Jacksonville PR Newswire
03-Jul-14 11:31AM  NxStage Joins Patients in Celebrating Independence PR Newswire
08:15AM  NxStage Medical reiterated Outperform after CMS rule at William Blair at theflyonthewall.com
16-Jun-14 04:30PM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial EDGAR Online
12-Jun-14 12:48PM  Avid Motorcyclist and NxStage Patient Reclaims His Life PR Newswire
28-May-14 05:11PM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
19-May-14 08:00AM  Flexibility of Home Hemodialysis with NxStage System One Allows Patient to Achieve Life Milestone PR Newswire
15-May-14 08:17AM  NxStage to Present at the William Blair Growth Stock Conference PR Newswire
08-May-14 03:09PM  NxStage Medical's (NXTM) CEO Jeff Burbank on Q1 2014 Results - Earnings Call Transcript at Seeking Alpha +8.84%
07:53AM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh EDGAR Online
07:26AM  NxStage Medical sees Q2 revenue $70M-$71.5M, consensus $70.46M at theflyonthewall.com
07:26AM  NxStage Medical sees FY14 revenue to be in higher end of $283M-$288M at theflyonthewall.com
07:25AM  NxStage Medical reports Q1 EPS (9c), consensus (11c) at theflyonthewall.com
07:22AM  NxStage Reports Record First Quarter 2014 Financial Results And Exceeds Guidance PR Newswire
07:07AM  Q1 2014 NxStage Medical, Inc. Earnings Release - Before Market Open CCBN
15-Apr-14 08:15AM  NxStage Patient Enjoys Travel and Active Lifestyle PR Newswire -6.67%
08-Apr-14 08:00AM  NxStage® to Report First Quarter 2014 Financial Results PR Newswire
31-Mar-14 08:37AM  NxStage Wins 2014 American Red Cross Northeast Chapter Workplace Hero Award PR Newswire
20-Mar-14 08:00AM  NxStage Establishes First Annual National Home Hemodialysis Day PR Newswire
11-Mar-14 12:53PM  Despite skepticism, market technicals remain bullish at MarketWatch -5.80%
10-Mar-14 01:58PM  Stocks: Insiders Buy at Opko Health and Synageva BioPharma, Sell at EXCO Resources at Minyanville
03-Mar-14 04:16PM  NXSTAGE MEDICAL, INC. Files SEC form 10-K, Annual Report EDGAR Online
27-Feb-14 02:58PM  NxStage Medical's CEO Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
08:55AM  NxStage Medical, Inc. Discusses Q4 2013 Results (Webcast) at Seeking Alpha
07:45AM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh EDGAR Online
07:31AM  NxStage Reports Record Fourth Quarter and Full-Year 2013 Financial Results PR Newswire
07:07AM  Q4 2013 NxStage Medical, Inc. Earnings Release - Before Market Open CCBN
24-Feb-14 08:00AM  Former NxStage Patient Celebrates Life Milestones PR Newswire
06-Feb-14 04:02PM  NxStage Medical Launches NxStage Plus One at 2014 Annual Dialysis Conference PR Newswire
21-Jan-14 08:24AM  NxStage® to Report Fourth Quarter and Full Year 2013 Financial Results PR Newswire
15-Jan-14 11:33PM  NxStage Medical CEO Presents at JPMorgan Healthcare Conference (Transcript) at Seeking Alpha
14-Jan-14 02:20PM  3 Stocks Spiking on Big Volume at TheStreet +10.52%
13-Jan-14 04:14PM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh EDGAR Online
04:05PM  NxStage Increases Revenue Guidance for Fourth Quarter and Full-Year 2013 PR Newswire
08-Jan-14 12:33PM  NxStage Gaining Ground On Growing Adoption Of Home Hemodialysis at Seeking Alpha +5.84%
06-Jan-14 05:09PM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events EDGAR Online
31-Dec-13 08:00AM  NxStage to Present at the 32nd Annual J.P. Morgan Healthcare Conference PR Newswire
05-Dec-13 11:02AM  Fundamentally And Technically, Fresenius Wins Big Over DaVita at Seeking Alpha
26-Nov-13 10:23AM  Is It Time to Buy These 4 Dialysis Stocks? at Motley Fool
25-Nov-13 10:24AM  Moving Average Crossover: Great News for NxStage Medical, Inc. (NXTM)? Zacks
09-Nov-13 09:09AM  3 Horrendous Health-Care Stocks This Week at Motley Fool
08-Nov-13 06:02PM  Nasdaq stocks posting largest percentage decreases AP
12:17AM  NxStage Medical's CEO Discusses Q3 2013 Results - Earnings Call Transcript at Seeking Alpha
07-Nov-13 02:43PM  Why NxStage Medical Inc. Shares Slumped at Motley Fool -16.01%
09:00AM  NxStage Medical, Inc. Earnings Call scheduled for 9:00 am ET today CCBN
08:55AM  NxStage Medical, Inc. Discusses Q3 2013 Results (Webcast) at Seeking Alpha
07:56AM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh EDGAR Online
07:42AM  InPlay: Nxstage Medical misses by $0.02, reports revs in-line; guides Q4 EPS below consensus, revs below consensus Briefing.com
07:31AM  NxStage Reports Third Quarter 2013 Financial Results PR Newswire
NxStage Medical, Inc., a medical device company, develops, manufactures, and markets products for the treatment of kidney failure, fluid overload, and related blood treatments and procedures. Its primary product is the NxStage System One, a portable hemodialysis system used for the treatment of acute and chronic kidney failure, and fluid overload. The company operates in two segments, System One and In-Center. The System One segment sells and rents the NxStage System One and PureFlow SL dialysate preparation equipment. This segment also sells extracorporeal disposable products, which are primarily used for in-center dialysis treatments for patients with end-stage renal disease (ESRD) in the home and critical care markets. The In-Center segment sells blood tubing sets and needles for hemodialysis primarily for the treatment of ESRD patients at dialysis centers; and needles for apheresis. NxStage Medical, Inc. markets its products through direct sales force and distributors to hospitals and dialysis centers in the United States and internationally. The company, formerly known as QB Medical, Inc., was founded in 1998 and is headquartered in Lawrence, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Brown Robert S.President, Kidney CareOct 23Option Exercise4.5443,470197,35491,098Oct 24 06:10 PM
Brown Robert S.President, Kidney CareOct 23Sale14.5343,470631,61947,628Oct 24 06:10 PM
Brown Robert S.President, Kidney CareOct 22Option Exercise4.541,9008,62649,528Oct 24 06:10 PM
Brown Robert S.President, Kidney CareOct 22Sale14.501,90027,55047,628Oct 24 06:10 PM
Burbank Jeffrey HCEOOct 20Sale14.007,584106,176821,481Oct 22 04:26 PM
Turk Joseph E JrPresidentOct 20Sale14.001,50021,000117,947Oct 21 06:24 PM
Swan Winifred LSVP and General CounselOct 15Option Exercise6.842,96820,30123,156Oct 17 04:34 PM
Swan Winifred LSVP and General CounselOct 15Sale13.013,46845,11919,688Oct 17 04:34 PM
Turk Joseph E JrPresidentSep 24Option Exercise6.202,55015,813122,997Sep 26 05:22 PM
Turk Joseph E JrPresidentSep 24Sale13.343,55047,357119,447Sep 26 05:22 PM
Burbank Jeffrey HCEOSep 19Sale14.002,41633,824829,065Sep 22 05:14 PM
Turk Joseph E JrPresidentSep 19Sale14.001,30018,200120,447Sep 22 05:13 PM
Turk Joseph E JrPresidentSep 18Sale14.002002,800121,747Sep 22 05:13 PM
Hershberger KevinChief Accounting OfficerSep 10Sale13.5884311,44824,717Sep 10 05:05 PM
Turk Joseph E JrPresidentSep 08Sale14.001,50021,000121,947Sep 08 06:34 PM
Burbank Jeffrey HCEOSep 08Sale14.002,32232,508831,481Sep 08 06:29 PM
Turk Joseph E JrPresidentAug 27Option Exercise5.791,5508,973125,997Aug 28 05:19 PM
Turk Joseph E JrPresidentAug 27Sale13.062,55033,303123,447Aug 28 05:19 PM
Swan Winifred LSVP and General CounselAug 15Option Exercise6.842,00013,68022,188Aug 18 05:18 PM
Swan Winifred LSVP and General CounselAug 15Sale13.602,00027,20020,188Aug 18 05:18 PM
Swan Winifred LSVP and General CounselAug 14Sale13.615006,80520,188Aug 18 05:18 PM
Burbank Jeffrey HCEOAug 07Sale14.005,00070,000833,803Aug 08 05:03 PM
Turk Joseph E JrPresidentAug 07Sale14.001,50021,000124,447Aug 08 05:02 PM
Burbank Jeffrey HCEOJul 25Option Exercise4.97296,8461,473,998933,557Jul 29 05:05 PM
Turk Joseph E JrPresidentJul 24Option Exercise6.202,55015,813129,497Jul 28 04:54 PM
Turk Joseph E JrPresidentJul 24Sale13.503,55047,925125,947Jul 28 04:54 PM
Swan Winifred LSVP and General CounselJul 18Option Exercise6.842,00013,68022,688Jul 22 06:46 PM
Swan Winifred LSVP and General CounselJul 18Sale13.462,00026,92020,688Jul 22 06:46 PM
Swan Winifred LSVP and General CounselJul 17Sale13.505006,75020,688Jul 21 05:07 PM
Turk Joseph E JrPresidentJun 24Option Exercise5.982,95017,629130,897Jun 24 05:23 PM
Turk Joseph E JrPresidentJun 24Sale14.433,95056,999126,947Jun 24 05:23 PM
Burbank Jeffrey HCEOJun 20Sale14.005,00070,000636,711Jun 23 04:29 PM
Turk Joseph E JrPresidentJun 17Sale14.001,50021,000127,947Jun 18 04:51 PM
Hershberger KevinChief Accounting OfficerJun 10Sale13.8784311,69227,246Jun 12 07:07 PM
Swan Winifred LSVP and General CounselJun 09Option Exercise7.058,72861,50830,416Jun 11 05:38 PM
Swan Winifred LSVP and General CounselJun 09Sale14.009,228129,19221,188Jun 11 05:38 PM
Swan Winifred LSVP and General CounselJun 05Option Exercise9.967,50074,70029,188Jun 09 05:00 PM
Turk Joseph E JrPresidentJun 05Sale14.001,50021,000129,447Jun 09 04:57 PM
Burbank Jeffrey HCEOJun 05Sale14.005,00070,000641,711Jun 09 04:55 PM
Swan Winifred LSVP and General CounselJun 05Sale14.007,500105,00021,688Jun 09 05:00 PM
Turk Joseph E JrPresidentMay 29Option Exercise5.943,03518,014134,982Jun 02 06:45 PM
Turk Joseph E JrPresidentMay 29Sale13.604,03554,876130,947Jun 02 06:45 PM
Swan Winifred LSVP and General CounselMay 15Option Exercise4.269,62941,02631,317May 16 05:52 PM
Swan Winifred LSVP and General CounselMay 15Sale12.809,629123,25121,688May 16 05:52 PM
Swan Winifred LSVP and General CounselMay 14Sale13.045,00065,20021,688May 15 05:07 PM
Hershberger KevinChief Accounting OfficerMay 12Sale12.7884310,77428,089May 19 06:31 PM
Brown Robert S.President, Kidney CareMar 09Option Exercise0.003,056048,665Mar 11 09:29 PM
Hershberger KevinChief Accounting OfficerMar 09Option Exercise0.001,146029,367Mar 11 09:14 PM
Turk Joseph E JrPresidentMar 09Option Exercise0.003,0560132,974Mar 11 09:05 PM
Swan Winifred LSVP and General CounselMar 09Option Exercise0.003,056027,727Mar 11 08:57 PM
FUNARI ROBERT GDirectorMar 06Buy14.7210,150149,40810,150Mar 07 04:48 PM
MOORE CRAIG WDirectorMar 05Option Exercise3.3814,00047,32098,750Mar 07 04:46 PM
Swan Winifred LSVP and General CounselMar 04Option Exercise0.003,675026,064Mar 06 07:11 PM
Turk Joseph E JrPresidentMar 04Option Exercise0.003,6750131,311Mar 06 07:10 PM
Hershberger KevinChief Accounting OfficerMar 04Option Exercise0.001,378028,744Mar 06 07:09 PM
Burbank Jeffrey HCEOMar 04Option Exercise0.0010,1070644,454Mar 06 07:08 PM
Brown Robert S.President, Kidney CareMar 04Option Exercise0.003,675047,002Mar 06 07:08 PM
Giannini Daniel ADirectorJan 02Option Exercise3.3814,00047,32067,540Jan 03 05:05 PM
REID PERPERDirectorDec 11Option Exercise3.3814,00047,320116,911Dec 13 06:48 AM
Turk Joseph E JrPresidentDec 10Option Exercise5.7417,422100,006127,636Dec 11 05:26 PM
Swan Winifred LSVP and General CounselDec 10Option Exercise5.472,99716,39422,389Dec 11 05:27 PM
Brown Robert S.President, Kidney CareDec 10Option Exercise3.1510,80534,04943,327Dec 12 05:02 PM
Burbank Jeffrey HCEODec 10Option Exercise5.4720,735113,420634,347Dec 12 05:00 PM
Burbank Jeffrey HCEONov 19Option Exercise5.4723,868130,558613,612Nov 20 05:27 PM